Target intelligence / Profile preview

Myeloid associated differentiation marker like (MYADML)

Target: MYADML

Overview

MYADML (Myeloid associated differentiation marker like) is a human pseudogene, closely related to MYADM, but does not encode a protein and is not involved in biological, pathological, or therapeutic processes. MYADML2 (a related gene) encodes a protein, but this is distinct from MYADML; much of the available literature and drug discovery information pertains to MYADM rather than MYADML. Care must be taken not to confuse MYADML with MYADM, which is a membrane protein involved in myeloid cell differentiation and airway inflammation.

Beyond the preview

Go deeper on Myeloid associated differentiation marker like (MYADML).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myeloid associated differentiation marker like (MYADML).

Explore the full profile